EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudie

Phenobarbital Versus Benzodiazepines for Alcohol Withdrawal in the Medical Intensive Care Unit (ICU): A Retrospective Cohort Study

Megan Ingebrigtson iD, Sarah Schang, Robert C Hyzy, Jakob I McSparron, Xi Chen, Elliot B Tapper, Michael T Kenes

Journal of Pharmacy Practice · 2025-04 · 38 (2) · 231-236

DOI: 10.1177/08971900241273144 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Pharmacy Practice, online erschienen am 11.09.2024. Verfasst von Megan Ingebrigtson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Michigan Medicine, Department of Clinical Pharmacy, College of Pharmacy, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Phenobarbital, Intensive Care Units, Benzodiazepines, Substance Withdrawal Syndrome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Michigan Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Phenobarbital (PHB) is a safe and efficacious alternative to benzodiazepines (BZD) for treating severe alcohol withdrawal (AWS). However, the safety of utilizing PHB for patients initially treated with BZD is unknown.

Objective

To evaluate the safety and efficacy of PBH compared to BZDs in severe AWS in the medical intensive care unit (ICU).

Methods

This was a retrospective cohort study comparing critically ill patients admitted for AWS who received BZDs or PHB. The primary outcome was time to persistent resolution of altered mentation. Secondary outcomes included development and duration of delirium, need for mechanical ventilation, development of withdrawal seizures, and ICU and hospital length of stay.

Results

Ninety-five patients were evaluated (53 in PHB group, 42 in BZD group). Before study medication, less BZD patients demonstrated abnormal mentation compared with PHB patients (RASS < -2: 2.39% vsvs. 28.12%, respectively, and RASS > +2: 9.9% vsvs. 48.76%; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenobarbitalIntensive Care UnitsBenzodiazepinesSubstance Withdrawal SyndromeAlcohol Withdrawal DeliriumHumansRetrospective StudiesMaleFemaleMiddle AgedCohort StudiesProhibitinsAdultAgedTreatment Outcome

Stichwörter der Autor:innen

AWSalcohol withdrawal deliriumdelirium tremensintensive care unitphenobarbital

Substanzen

PhenobarbitalBenzodiazepinesProhibitinsPHB protein, human

Autor:innen und Institutionen

  • Department of Pharmacy, Michigan Medicine, Department of Clinical Pharmacy, College of Pharmacy, Ann Arbor, MI, USA.
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.

ORCID-Profile: Megan Ingebrigtson

Förderung

  • Michigan Medicine

Zitieren

APA

Ingebrigtson, M., Schang, S., Hyzy, R. C., McSparron, J. I., Chen, X., Tapper, E. B., & Kenes, M. T. (2025). Phenobarbital Versus Benzodiazepines for Alcohol Withdrawal in the Medical Intensive Care Unit (ICU): A Retrospective Cohort Study. Journal of Pharmacy Practice, 38(2), 231-236. https://doi.org/10.1177/08971900241273144

Vancouver

Ingebrigtson M, Schang S, Hyzy RC, McSparron JI, Chen X, Tapper EB, et al. Phenobarbital Versus Benzodiazepines for Alcohol Withdrawal in the Medical Intensive Care Unit (ICU): A Retrospective Cohort Study. Journal of Pharmacy Practice. 2025;38(2):231-236. doi:10.1177/08971900241273144

BibTeX
@article{Ingebrigtson2025,
  author = {Ingebrigtson, Megan and Schang, Sarah and Hyzy, Robert C and McSparron, Jakob I and Chen, Xi and Tapper, Elliot B and Kenes, Michael T},
  title = {Phenobarbital Versus Benzodiazepines for Alcohol Withdrawal in the Medical Intensive Care Unit (ICU): A Retrospective Cohort Study},
  journal = {Journal of Pharmacy Practice},
  year = {2025},
  volume = {38},
  number = {2},
  pages = {231--236},
  doi = {10.1177/08971900241273144}
}
Kostenlos starten →